Metabolism of arsenic in human liver: The role of membrane transporters

Archives of Toxicology

Volumn 84, Issue 1, 2010, Pages 3-16

  Drobná, Zuzana ^a   Walton, Felecia S ^a   Paul, David S ^a   Xing, Weibing ^b,c   Thomas, David J ^d   Stýblo, Miroslav ^a,e  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Human liver; Membrane transport

Indexed keywords

AQUAPORIN 9; ARSENIC; CACODYLIC ACID; GLUCOSE TRANSPORTER 2; GLYCOPROTEIN P; INORGANIC COMPOUND; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3;

CELL CULTURE; CULTURE MEDIUM; GENOTYPE; HUMAN; LIVER CELL; LIVER METABOLISM; MEMBRANE TRANSPORT; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

AGED; AGED, 80 AND OVER; ANIMALS; ARSENIC; CELL MEMBRANE; CELLS, CULTURED; FEMALE; GLUCOSE TRANSPORTER TYPE 2; HUMANS; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; METHYLATION; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 76749162294     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-009-0499-7     Document Type: Review

References (74)

1. L Benbrahim-Tallaa RA Waterland M Styblo WE Achanzar MM Webber MP Waalkes 2005 Molecular events associated with arsenic induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and oncogene activation Toxicol Appl Pharmacol 206 288 298 10.1016/j.taap.2004.11. 017 1:CAS:528:DC%2BD2MXmsVWgur8%3D 16039940 (Pubitemid 41020671)
2. L Benramdane M Accominotti L Fanton D Malicier J-J Vallon 1999 Arsenic speciation in human organs following fatal arsenic trioxide poisoning-a case report Clin Chem 45 301 306 1:CAS:528:DyaK1MXhtFGltbs%3D 9931060
3. H Bhattacharjee J Carbrey BP Rosen R Mukhopadhyay 2004 Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9 Biochem Biophys Res Commun 322 836 841 10.1016/j.bbrc.2004.08.002 1:CAS:528: DC%2BD2cXntFeqsb4%3D 15336539 (Pubitemid 39164428)
4. EM Brambila WE Achanzar W Qu MM Webber MP Waalkes 2002 Chronic arsenic-exposed human prostate epithelial cells exhibit stable arsenic tolerance: mechanistic implications of altered cellular glutathione and glutathione S-transferase Toxicol Appl Pharmacol 183 99 107 10.1016/S0041- 008X(02)99468-8 1:CAS:528:DC%2BD38XnslGrsb0%3D 12387749 (Pubitemid 35286138)
5. TG Bredfeldt B Jagadish KE Eblin EA Mash AJ Gandolfi 2006 Monomethylarsonous acid induces transformation of human bladder cells Toxicol Appl Pharmacol 216 69 79 10.1016/j.taap.2006.04.011 1:CAS:528: DC%2BD28XpvV2mtbs%3D 16806342 (Pubitemid 44402634)
6. JP Buchet R Lauwerys 1985 Study of inorganic arsenic methylation by rat in vitro: relevance for the interpretation of observations in man Arch Toxicol 57 125 129 10.1007/BF00343122 1:CAS:528:DyaL2MXkvVaqsL4%3D 4026571 (Pubitemid 15028765)
7. JP Buchet A Geubel S Pauwels P Mahieu R Lauwerys 1984 The influence of liver disease on the methylation of arsenite in humans Arch Toxicol 55 151 154 10.1007/BF00316119 1:STN:280:DyaL2M%2FksF2rsw%3D%3D 6497648 (Pubitemid 15201559)
8. SM Cohen T Ohnishi LL Arnold XC Le 2007 Arsenic-induced bladder cancer in an animal model Toxicol Appl Pharmacol 222 258 263 10.1016/j.taap.2006.10.010 1:CAS:528:DC%2BD2sXovFKqurk%3D 17109909 (Pubitemid 47198272)
9. WR Cullen BC McBride J Reglinski 1984 The reaction of methylarsenicals with thiols: some biological implications J Inorg Biochem 21 179 194 10.1016/0162-0134(84)83002-0 1:CAS:528:DyaL2cXlt1Ggt7Y%3D
10. M Delnomdedieu MM Basti JD Otvos DJ Thomas 1994 Reduction and binding of arsenate and dimethylarsenate by glutathione: a multinuclear magnetic resonance study Chem-Biol Interact 90 139 155 10.1016/0009-2797(94)90099-X 1:CAS:528:DyaK2cXjtFOnt7c%3D 8156604 (Pubitemid 24103849)
11. V Devesa LM Del Razo B Adair Z Drobná SB Waters MF Hughes M Styblo DJ Thomas 2004 Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry J Anal At Spectrom 19 1460 1467 10.1039/b407388f 1:CAS:528:DC%2BD2cXpt1OmtL4%3D
12. Z Drobná I Jaspers DJ Thomas M Styblo 2003 Differential activation of AP-1 in human bladder epithelial cells by inorganic and methylated arsenicals FASEB J 17 67 69 12475910
13. Z Drobná SB Waters FS Walton EL LeCluyse DJ Thomas M Styblo 2004 Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes Toxicol Appl Pharmacol 201 166 177 10.1016/j.taap.2004.05.004 15541756 (Pubitemid 39487164)
14. Z Drobná SB Waters V Devesa AW Harmon DJ Thomas M Stýblo 2005 Metabolism and toxicity of As in human urothelial cells expressing rat arsenic (+3 oxidation state) methyltransferase Toxicol Appl Pharmacol 207 147 159 10.1016/j.taap.2004.12.007 16102566 (Pubitemid 41133501)
15. Z Drobná W Xing DJ Thomas M Stýblo 2006 shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells Chem Res Toxicol 19 894 898 10.1021/tx060076u 16841956 (Pubitemid 44092355)
16. AP Geubel MC Mairlot JP Buchet C Dive R Lauwerys 1988 Abnormal methylation capacity in human liver cirrhosis Int J Pharm Res VIII 2 117 122
17. SM Healy E Wildfang RA Zakharyan HV Aposhian 1999 Diversity of inorganic arsenite biotransformation Biol Trace Element Res 68 249 266 10.1007/BF02783907 1:CAS:528:DyaK1MXjtVKqtbs%3D
18. GW Hepner ES Vesell 1975 Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine Ann Internal Med 83 632 638 1:CAS:528:DyaE28XislKqsw%3D%3D
19. A Hernández N Xamena C Sekaran H Tokunaga A Sampayo-Reyes D Quinteros A Creus R Marcos 2008 High arsenic metabolic efficiency in AS3MT287Thr allele carriers Pharmacogenet Genomics 18 349 355 10.1097/FPC.0b013e3282f7f46b 18334919
20. A Hernández N Xamena J Surrallés C Sekaran H Tokunaga D Quinteros A Creus R Marcos 2008 Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile Mutat Res 637 80 92 17850829
21. M Hirata T Mohri A Hisanaga N Ishinishi 1989 Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from livers and kidneys of rats and mice Appl Organomet Chem 3 335 341 10.1002/aoc.590030406 1:CAS:528:DyaL1MXlvVyqu7s%3D
22. KA Hoffmaster RZ Turncliff EL LeCluyse RB Kim PJ Meier KLR Brouwer 2004 P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide Pharm Res 21 1294 1302 10.1023/B:PHAM.0000033018.97745. 0d 1:CAS:528:DC%2BD2cXltF2gsb8%3D 15290872 (Pubitemid 38954216)
23. SV Kala MW Neely G Kala CI Prater DW Atwood JS Rice MW Lieberman 2000 The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic J Biol Chem 275 33404 33408 10.1074/jbc.M007030200 1:CAS:528:DC%2BD3cXnvVOqu7o%3D 10938093 (Pubitemid 30808550)
24. C Kiermayer B Michalke J Schmidt M Brielmeier 2007 Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice Biol Chem 388 1091 1097 10.1515/BC.2007.133 1:CAS:528:DC%2BD2sXhtFCnt77J 17937623 (Pubitemid 47584308)
25. J Konig D Rost Y Cui D Keppler 1999 Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane Hepatology 29 1156 1163 10.1002/hep.510290404 1:CAS:528:DyaK1MXisVKgsb8%3D 10094960
26. S Lee J Kim K Kwon HW Yoon RL Levine A Ginsburg SG Rhee 1999 Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver J Biol Chem 274 4722 4734 10.1074/jbc.274.8.4722 1:CAS:528:DyaK1MXhsFSmu78%3D 9988709 (Pubitemid 29113369)
27. TC Lee IC Ho WJ Lu JD Huang 2006 Enhanced expression of Multidrug resistance-associated protein 2 and reduced expression of Aquaglyceroporin 3 in am arsenic-resistant human cell line J Biol Chem 281 18401 18407 10.1074/jbc.M601266200 1:CAS:528:DC%2BD28XmsVagtr4%3D 16672223 (Pubitemid 44035498)
28. J Leung A Pang WH Yuen YL Kwong EWC Tse 2007 Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells Blood 109 740 746 10.1182/blood-2006-04-019588 1:CAS:528:DC%2BD2sXivVyrsL8%3D 16968895 (Pubitemid 46105976)
29. S Lin WR Cullen DJ Thomas 1999 Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase Chem Res Toxicol 12 924 930 10.1021/tx9900775 1:CAS:528:DyaK1MXlslChs7c%3D 10525267 (Pubitemid 29498365)
30. S Lin Q Shi FB Nix M Styblo MA Beck KM Herbin-Davis LL Hall JB Simeonsson DJ Thomas 2002 A novel S-Adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol J Biol Chem 277 10795 10803 10.1074/jbc.M110246200 1:CAS:528:DC%2BD38Xis1Kht7k%3D 11790780 (Pubitemid 34952833)
31. AL Lindberg R Kumar W Goessler R Thirumaran E Gurzau K Koppova P Rudnai G Leonardi T Fletcher M Vahter 2007 Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms Environ Health Perspect 115 1081 1086 1:CAS:528:DC%2BD2sXosFSjs74%3D 17637926
32. J Liu H Chen DS Miller JE Saavedra LK Keefer DR Johnson CD Klaassen MP Waalkes 2001 Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic Mol Pharmacol 60 302 309 1:CAS:528:DC%2BD3MXlsFansbk%3D 11455017
33. Z Liu J Shen JM Carbrey R Mukhopadhyay P Agre BP Rosen 2002 Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9 Proc Natl Acad Sci USA 99 6053 6058 10.1073/pnas.092131899 1:CAS:528:DC%2BD38XjslWgu7g%3D 11972053 (Pubitemid 34493263)
34. Z Liu JM Carbrey P Agre BP Rosen 2004 Arsenic trioxide uptake by human and rat aquaglyceroporins Biochem Biophys Res Commun 316 1178 1185 10.1016/j.bbrc.2004.03.003 1:CAS:528:DC%2BD2cXisVKmsLo%3D 15044109 (Pubitemid 38369077)
35. Z Liu M Styblo BP Rosen 2006 Methylarsonous acid transport by aquaglyceroporins Environ Health Perspect 114 527 531 1:CAS:528: DC%2BD28Xktlegu78%3D 16581540
36. Z Liu MA Sanchez X Jiang E Boles SM Landfear BP Rosen 2006 Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid Biochem Biophys Res Commun 351 424 430 10.1016/j.bbrc.2006. 10.054 1:CAS:528:DC%2BD28XhtFOjtrvJ 17064664 (Pubitemid 44666705)
37. WJ Lu I Tamai J Nezu ML Lai JD Huang 2006 Organic anion transporting polypeptide-C mediates arsenic uptake in HEK-293 cells J Biomed Sci 13 525 533 10.1007/s11373-006-9071-0 1:CAS:528:DC%2BD28XpsVCisb0%3D 16479312
38. C Mahagita SM Grassl P Piyachaturawat N Ballatori 2007 Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport Am J Physiol Gastrointest Liver Physiol 293 G271 G278 10.1152/ajpgi.00075.2007 1:CAS:528:DC%2BD2sXosV2mu7o%3D 17412826
39. P Maheu JP Buchet HA Roels R Lauwerys 1987 The metabolism of arsenic in humans acutely intoxicated by As2O3 Clin Toxicol 18 1067 1075 10.3109/15563658108990336
40. E Marafante M Vahter J Envall 1985 The role of methylation in the detoxification of arsenate in the rabbit Chem-Biol Interact 56 225 238 10.1016/0009-2797(85)90008-0 1:CAS:528:DyaL28XotlejtQ%3D%3D 4075449 (Pubitemid 16173392)
41. MJ Mass A Tennant BC Roop WR Cullen M Styblo DJ Thomas AD Kligerman 2001 Methylated trivalent arsenic species are genotoxic Chem Res Toxicol 14 355 361 10.1021/tx000251l 1:CAS:528:DC%2BD3MXhsVantLY%3D 11304123 (Pubitemid 32367468)
42. Y Moriwaki T Yamamoto K Higashino 1999 Enzymes involved in purine metabolism-a review of histochemical localization and functional implications Histol Histopathol 14 1321 1340 1:CAS:528:DyaK1MXmsVGlsrs%3D 10506947
43. K Mure AN Uddin LC Lopez M Styblo TG Rossman 2003 Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations Environ Mol Mutagen 41 322 331 10.1002/em.10164 1:CAS:528:DC%2BD3sXls1WnsLc%3D 12802802 (Pubitemid 36759073)
44. H Naranmandura K Ibata KT Suzuki 2007 Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells Chem Res Toxicol 2 1120 1125 10.1021/tx700103y (Pubitemid 47372990)
45. B Németi I Csanaky Z Gregus 2006 Effect of an inactivator of glyceraldehyde-3-phosphate dehydrogenase, a fortuitous arsenate reductase, on disposition of arsenate in rats Tox Sci 90 49 60 10.1093/toxsci/kfj058 (Pubitemid 43264726)
46. DS Paul AW Harmon V Devesa DJ Thomas M Styblo 2007 Molecular mechanisms of diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid Environ Health Perspect 115 734 742 1:CAS:528: DC%2BD2sXmt1Sksbw%3D 17520061
47. L Payen A Courtois JP Campion A Guillouzo O Fardel 2000 Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes Biochem Pharmacol 60 1967 1975 10.1016/S0006-2952(00) 00496-2 1:CAS:528:DC%2BD3cXosFCitb8%3D 11108814
48. JS Petrick F Ayala-Fierro WR Cullen DE Carter VH Aposhian 2000 Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes Toxicol Appl Pharmacol 163 203 207 10.1006/taap.1999.8872 1:CAS:528:DC%2BD3cXhsVSnurw%3D 10698679 (Pubitemid 30152096)
49. JS Petrick B Jagadish EA Mash HV Aposhian 2001 Monomethylarsonous acid (MMAIII) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase Chem Res Toxicol 14 651 656 10.1021/tx000264z 1:CAS:528: DC%2BD3MXjvFSlurY%3D 11409934
50. C Planchamp A Hadengue B Stieger J Bourquin A Vonlaufen JL Frossard R Quadri CD Becker CM Pastor 2007 Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes Mol Pharmacol 71 1089 1097 10.1124/mol.106.030759 1:CAS:528:DC%2BD2sXkt1Ohu70%3D 17234897 (Pubitemid 46457012)
51. R Raml A Rumpler W Goessler M Vahter L Li T Ochi KA Francesconi 2007 Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh Toxicol Appl Pharmacol 222 374 380 10.1016/j.taap.2006.12.014 1:CAS:528:DC%2BD2sXovFOjsr8%3D 17276472 (Pubitemid 47198276)
52. PF Reay CJ Asher 1977 Preparation and purification of 74As-labeled arsenate and arsenite for use in biological experiments Anal Biochem 78 557 560 10.1016/0003-2697(77)90117-8 1:CAS:528:DyaE2sXhtFOitro%3D 851228
53. PJ Roach 2002 Glycogen and its metabolism Curr Mol Med 2 101 120 10.2174/1566524024605761 1:CAS:528:DC%2BD38XivVaqt70%3D 11949930
54. DA Sens S Park V Gurel MA Sens SH Garrett S Somji 2004 Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells Toxicol Sci 79 56 63 10.1093/toxsci/kfh086 1:CAS:528:DC%2BD2cXjs1Wqs70%3D 14976345 (Pubitemid 38660248)
55. M Styblo DJ Thomas 1997 Binding of arsenicals to proteins in an in vitro methylation system Toxicol Appl Pharmacol 147 1 8 10.1006/taap.1997.8256 1:CAS:528:DyaK2sXnt1enurc%3D 9356301 (Pubitemid 27490389)
56. Styblo M, Delnomdedieu M, Thomas DJ (1995a) Biological mechanism and toxicological consequences of the methylation of arsenic. In: Goyer RA, Cherian MG (eds) Handbook of experimental pharmacology, vol 115, toxicology of metals-biochemical aspects. Springer, New York, pp 407-433
57. M Styblo H Yamauchi DJ Thomas 1995 Comparative in vitro methylation of trivalent and pentavalent arsenic species Toxicol Appl Pharmacol 135 172 178 10.1006/taap.1995.1220 1:CAS:528:DyaK28XhvFSgsg%3D%3D 8545824 (Pubitemid 26031867)
58. M Styblo SV Serves WR Cullen DJ Thomas 1997 Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols Chem Res Toxicol 10 27 33 10.1021/tx960139g 1:CAS:528:DyaK2sXmtVOktw%3D%3D 9074799 (Pubitemid 27044904)
59. M Styblo LM Del Razo EL LeCluyse GA Hamilton C Wang WR Cullen DJ Thomas 1999 Metabolism of arsenic in primary cultures of human and rat hepatocytes Chem Res Toxicol 12 560 565 10.1021/tx990050l 1:CAS:528:DyaK1MXjvFGiur8%3D 10409394 (Pubitemid 29354737)
60. M Styblo LM Del Razo L Vega DR Germolec EL LeCluyse GA Hamilton W Reed C Wang WR Cullen DJ Thomas 2000 Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in human cells Arch Toxicol 74 289 299 10.1007/s002040000134 1:CAS:528:DC%2BD3cXnt1Wjtb8%3D 11005674 (Pubitemid 30660931)
61. M Styblo Z Drobná I Jaspers S Lin DJ Thomas 2002 The role of biomethylation in toxicity and carcinogenicity of arsenic. A research update Environ Health Perspect 110 Suppl 5 767 771 1:CAS:528:DC%2BD38XovFKhsLg%3D 12426129
62. A Takeshita K Shinjo K Naito H Matsui K Shigeno S Nakamura T Horii M Maekawa K Kitamura T Naoe K Ohmishi R Ohno 2003 P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As2O3), but are not the main mechanism of As2O3-resistance in acute promyelotic leukemia cells Leukemia 17 648 650 10.1038/sj.leu.2402851 1:CAS:528:DC%2BD3sXitFenurs%3D 12646961 (Pubitemid 36395665)
63. DJ Thomas M Styblo L Shan 2001 Cellular metabolism and systemic toxicity of arsenic Toxicol Appl Pharmacol 176 127 144 10.1006/taap.2001.9258 1:CAS:528:DC%2BD3MXnsFGjt7c%3D 11601889 (Pubitemid 33015863)
64. DJ Thomas J Li SB Waters W Xing BM Adair Z Drobna V Devesa M Styblo 2007 Arsenic (+3 oxidation state) methyltransferase and methylation of arsenicals Exp Biol Med 232 3 13 1:CAS:528:DC%2BD2sXmslaqtw%3D%3D
65. L Vega M Styblo R Patterson W Cullen C Wang D Germolec 2001 Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes Toxicol Appl Pharmacol 172 225 232 10.1006/taap.2001.9152 1:CAS:528:DC%2BD3MXivVehsbc%3D 11312651 (Pubitemid 32406030)
66. L Vernhet MP Seite N Allain A Guillouzo O Fardel 2001 Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes J Pharmacol Exp Ther 298 234 239 1:CAS:528:DC%2BD3MXksFChur4%3D 11408547
67. III-methyltransferase and the methylation of arsenite by rat and human hepatocytes Chem Res Toxicol 16 261 265 10.1021/tx025649r 1:CAS:528:DC%2BD3sXht1Oht74%3D 12641425 (Pubitemid 36373690)
68. FS Walton AW Harmo DS Paul Z Drobná YM Patel M Styblo 2004 Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes Toxicol Appl Pharmacol 198 424 433 10.1016/j.taap.2003.10.026 1:CAS:528:DC%2BD2cXmtVaiu7c%3D 15276423 (Pubitemid 38969972)
69. SB Waters V Devesa-Perez LM Del Razo M Styblo DJ Thomas 2004 Endogenous reductants support catalytic function of recombinant rat cyt19, an arsenic methyltransferase Chem Res Toxicol 17 404 409 10.1021/tx0342161 1:CAS:528:DC%2BD2cXht1aiu70%3D 15025511 (Pubitemid 38375065)
70. SB Waters V Devesa MW Fricke JT Creed M Styblo DJ Thomas 2004 Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase- catalyzed formation of trimethylarsine oxide and trimethylarsine Chem Res Toxicol 17 1621 1629 10.1021/tx0497853 1:CAS:528:DC%2BD2cXps1Wqs7c%3D 15606138 (Pubitemid 39665554)
71. TC Wood O Salavagionne B Mukherjee L Wang AF Klumpp BA Thomae BW Eckloff DJ Schaid EC Wieben RM Weinshilboum 2006 Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies J Biol Chem 281 7364 7373 10.1074/jbc.M512227200 1:CAS:528:DC%2BD28Xit1ygtrc%3D 16407288 (Pubitemid 43847506)
72. Y Xie J Liu Y Liu CD Klaassen MP Waalkes 2004 Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice Mol Cell Biochem 255 11 18 10.1023/B:MCBI.0000007256.44450. 8c 1:CAS:528:DC%2BD3sXps1Shurs%3D 14971641 (Pubitemid 38159761)
73. ZL Yin JE Dahlstrom DG Le Couteur PG Board 2001 Immunohistochemistry of omega class glutathione S-transferase in human tissues J Histochem Cytochem 49 983 987 1:CAS:528:DC%2BD3MXlsVKrtr0%3D 11457926
74. L Zhou Y Jing M Styblo Z Chen S Waxman 2005 Glutathione S-transferase π inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide Blood 105 1198 1203 10.1182/blood-2003-12-4299 1:CAS:528: DC%2BD2MXhtFCgt7k%3D 15231573 (Pubitemid 40170894)